Siemens Healthineers AG buy BlueGraySphere
Start price
26.02.21
/
40%
€45.62
Target price
26.02.23
€55.00
Performance (%)
22.36%
End price
09.06.22
€55.82
Summary
This prediction ended on 09.06.22 with a price of €55.82. The prediction had a final performance of 22.36%. A total of €0.85 was paid as dividends for this prediction. BlueGraySphere has 40% into this predictionSiemens Healthineers is a multinational medical technology company headquartered in Germany, that provides medical solutions and services to healthcare providers around the world. The company operates in three main segments: imaging, laboratory diagnostics, and advanced therapies, offering a wide range of medical devices and systems, laboratory diagnostics, and digital health solutions to improve patient care and optimize efficiency in the healthcare industry. In addition, Siemens Healthineers is listed on the Frankfurt and US stock exchanges, with a market capitalization of over $70 billion as of 2021, making it one of the largest medical technology companies in the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Siemens Healthineers AG | -5.432% | -5.432% | -4.479% | 8.732% |
| iShares Core DAX® | -1.670% | -1.001% | 10.864% | 12.563% |
| iShares Nasdaq 100 | -4.184% | -1.145% | 37.458% | 41.078% |
| iShares Nikkei 225® | -4.967% | -5.783% | 18.828% | 0.655% |
| iShares S&P 500 | -2.834% | -0.572% | 25.875% | 39.960% |
According to BlueGraySphere what are the pros and cons of Siemens Healthineers AG for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Innovative
Known brand
Very Future proof/growth oriented business model
Stable Large shareholder and/or long term investor
Cons
Higher risks for its business